The significance of COMT activity in controlling dopamine agonist levels in brain and serum: Studies with a prodrug and a metabolite of 6,7-ADTN
- 1 June 1980
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 64 (4) , 313-323
- https://doi.org/10.1016/0014-2999(80)90239-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1980
- A new dopaminergic prodrugNature, 1978
- Facile syntheses of potent dopaminergic agonists and their effects on neurotransmitter releaseJournal of Medicinal Chemistry, 1978
- Catecholamines and related compoundsJournal of Chromatography B: Biomedical Sciences and Applications, 1978
- A potential anti-Parkinson drug, N-n-propyl-N-n-butyl-.beta.-(3,4-dihydroxyphenyl)ethylamine hydrochloride, and its effects in intact and nigra-lesioned ratsJournal of Medicinal Chemistry, 1978
- Design of agents for stimulation of neostriatal dopaminergic mechanismsJournal of Pharmacy and Pharmacology, 1974
- Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topographyNature, 1974
- O-methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviourEuropean Journal of Pharmacology, 1973
- The in Vivo Effect of Tropolone on Dopamine Metabolism and the Catechol-O-Methyl Transferase Activity in the Striatum of the RatActa Pharmacologica et Toxicologica, 1972
- The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouseBritish Journal of Pharmacology, 1969